Blog & News
Dr. Katie Carlberg Joins WNY BloodCare Clinical Team
Dr. Katie Carlberg is the newest physician addition to WNY BloodCare’s clinical team. Dr Carlberg is board certified in both general pediatrics and pediatric hematology/oncology and is a clinician at Roswell Park Cancer Institute. Before taking the role at WNY...
Discovery & Innovation Research Awards – Commitment to Patient Health
Discovery & Innovation Research Awards – Commitment to Patient Health This past March, as the country recognized Bleeding Disorder Awareness Month, WNY BloodCare (WNYBC), announced 2023 grant award funding to two research initiatives. WNYBC’s Discovery &...
WNYBC 3rd Research Symposium – Gene Therapies for Non-Malignant Hematologic Conditions
WNYBC hosted the 3rd Hemostasis Thrombosis Research Symposium on May 2 at UB’s Jacobs School of Medicine. This year’s overarching topic spotlighted Gene Therapies for Non-Malignant Hematologic Conditions. Attendees participated virtually and in-person. The Symposium...
WNYBC’s Pharmacy Director makes patient care priority
Ryan Hare, PharmD, BCOP (Board Certified in Oncology Pharmacy), is excited to combine his love for science with his desire to help others. Dr. Hare is the Pharmacy Director brought on to head WNYBC’s specialty in-house pharmacy services critical to the long-term...
Fallfest & Education Day brings Chris Bombardier to Western NY
Chris Bombardier is an internationally known mountain climber and outdoorsman who conquered the Seven Summits. He is one of only about 500 people who have achieved this feat since the idea of doing so was first conceived in the 1950s. He is the subject of a film,...
Meet Emily Diaz, F-NP
WNY BloodCare Family Nurse Practitioner, Emily Diaz always had an interest in healthcare. She was drawn to help others from an early age. She started volunteering at South Buffalo Mercy Hospital when she was just 14 years old. Emily attended SUNY Geneseo and...
Biomarin Provides Hemophilia A Clinical Development Program Updates
BioMarin recently shared a community update on their Hemophilia A Clinical Development Program for valoctocogene roxaparvovec, the company’s investigational gene therapy currently under review by the U.S. Food and Drug Administration (FDA). It included a brief...
National Hemophilia Foundation Set to Celebrate 75 Years in 2023
Organization set to look back while moving ahead during historic year NEW YORK — In 2023, the National Hemophilia Foundation (NHF) reaches its jubilee year with a special 75th anniversary celebration. To note this historic milestone, NHF is launching a year-long...
WNYBC & UB Partnership
Western New York BloodCare is proud to be included in the University at Buffalo’s circle of visionaries. Our growing partnership with UB has been in the works and is finally coming to fruition with programs that allow students a deeper understanding of our patient...
Accumulator Bill (S.5299-A) Passed Senate Unanimously!
Many thanks to Majority Leader Andrea Stewart-Cousins, Senator Gustavo Rivera, and the entire NY Senate for passing S.5299-A to help New Yorkers afford their medications and ensure that #AllCopaysCount!
